HI SCR173

Urges the U.S. Food and Drug Administration to expedite approval of new nonprescription sunscreen active ingredients that have pending Time and Extent Applications from the sunscreen industry.

Notes that the FDA has not approved any pending applications for nonprescription sunscreen active ingredients despite their demonstrated safe and effective use globally.

States that limited approved sunscreen ingredients in the U.S. have hampered industry innovation and prevented consumers from accessing alternative sunscreen products available elsewhere.

Calls on the FDA to work collaboratively with relevant stakeholders to approve ingredients that provide consumers with greater access and choice while enabling industry innovation.

Directs transmission of certified copies to the FDA Commissioner, U.S. Senate and House leadership, Hawaii's congressional delegation, and presiding officers of all state legislatures.